The role of Epstein–Barr virus in acute and chronic hepatitis

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 67, Issue 3, Pages (September 2017)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Alan Hoofring, John Boitnott, Michael Torbenson  Journal of Hepatology 
The role of Epstein–Barr virus in acute and chronic hepatitis
Volume 51, Issue 3, Pages (September 2009)
Volume 68, Issue 5, Pages (May 2018)
Hepatitis induced by Kava (Piper methysticum rhizoma)
Volume 61, Issue 6, Pages (December 2014)
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 57, Issue 1, Pages 6-8 (July 2012)
Immigration and viral hepatitis
Regulatory T-cell directed therapies in liver diseases
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Maya Srivastava, Antonio Perez–Atayde, Maureen M. Jonas 
Volume 44, Issue 5, Pages (May 2006)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Regulatory T-cell directed therapies in liver diseases
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
What is the long-term outcome of the liver allograft?
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
De novo autoimmune hepatitis after liver transplantation
Volume 50, Issue 4, Pages (April 2009)
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 56, Issue 6, Pages (June 2012)
Volume 44, Issue 4, Pages (April 2006)
Chetana Lim, Chady Salloum, Daniel Azoulay
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Statins: Old drugs as new therapy for liver diseases?
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
The relationship between age and fat infiltration in liver and muscle
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Presentation transcript:

The role of Epstein–Barr virus in acute and chronic hepatitis Uta Drebber, Hans U. Kasper, Joanna Krupacz, Katharina Haferkamp, Michael A. Kern, Hans M. Steffen, Maria Quasdorff, Axel zur Hausen, Margarete Odenthal, Hans P. Dienes  Journal of Hepatology  Volume 44, Issue 5, Pages 879-885 (May 2006) DOI: 10.1016/j.jhep.2006.02.006 Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Liver tissue with the typical changes of EBV hepatitis. A linear sinusoidal lymphocytic infiltrate (arrows) is seen in the acinus with little corresponding hepatocellular damage (A and B). Portal tract infiltration shows lymphocytes with conspicious interface activity (B) (HE stain, A×200, B×400). Journal of Hepatology 2006 44, 879-885DOI: (10.1016/j.jhep.2006.02.006) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 2 EBER–RISH with a positive dark brown signal within infiltrating lymphocytes (arrows). No virus is seen within hepatocytes, bile duct epithel or endothel (×400). Journal of Hepatology 2006 44, 879-885DOI: (10.1016/j.jhep.2006.02.006) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions